Professor Michael Yang Mengsu, Senior Vice-President (Innovation and Enterprise) of CityU (second from right) and Dr Sujuan Ba (second from left) signed the MoU, witnessed by Mr Lester Garson Huang, Council Chairman of CityU (first from right), and Ms Lillian Cheong, Under…
The U.S. Chinese Anti-Cancer Association (USCACA) and AFCR are pleased to invite nominations for the USCACA-‐AFCR 2023 Young Investigator Awards.
The Awards will recognize 3 to 5 junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research.
Candidacy…
Standing Together for a Greater Cause
In a remarkable display of unity, Dr. Sujuan B., CEO of the Asian Fund for Cancer Research (AFCR), and Dr. Kwok Leung, CFO, proudly stood shoulder to shoulder with the Global Coalition for Adaptive…
FOR IMMEDIATE RELEASE:
1 February 2023
CONTACTS:
Hugill & Ip Solicitors
Marco Raccuia, Head of Finance & Operations
E-mail: marco.raccuia@hugillandip.com
World Cancer Day - held every 4 February - is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education, and catalysing personal, collective and government action,…
As the year comes to a close, I wanted to reach out and ask for your support in our year-end fundraising campaign. Your generosity has the power to ignite a spark of hope for cancer patients and their families who are fighting an incredibly difficult…
The Asian Fund for Cancer Research Limited (AFCR) is saddened by the loss of George Sai Wah Tsao, Ph.D., who was a professor at the School of Biomedical Sciences and the Director of the Faculty Core Facility of the Faculty of Medicine…
By November 10, 2022, 94% (95% CrI, 79%-99%) of the US population were estimated to have been infected by SARS-CoV-2 at least once. Combined with vaccination, 97% (95%-99%) were estimated to have some prior immunological exposure to SARS-CoV-2. Between December 1, 2021…
I am writing today to ask for your 2022 Annual Fund renewal gift to the Asian Fund for Cancer Research, and your decision is absolutely crucial! Currently, talented scientists are waiting for funding to pursue potentially life-saving research projects . Generous friends…
Since 2020 AFCR has funded a novel multi-targeting immunotherapeutic platform that we envisioned could provide a safe and effective treatment for gastrointestinal (GI) cancers. Today I am excited to share with you the program's recent great progress!
With your previous support and…
The Asian Fund for Cancer Research Limited congratulates world-renowned neuroscientist, Nancy Ip, Ph.D., the Morningside Professor of Life Science and Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of Science and Technology (HKUST) on her appointment…